Bristol-Myers Squibb Co. (BMY)
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus infection. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Sustiva Franchise; the Reyataz Franchise; and Hepatitis C Franchise.
Bristol-Myers Squibb SEC Filing Email Alerts Service
| Company Name: |
Bristol-Myers Squibb Co. |
| Website: |
www.bms.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding BMY: |
86 |
| Total Market Value Held by ETFs: |
$3.16B |
| Total Market Capitalization: |
$83.73B |
| % of Market Cap. Held by ETFs: |
3.78% |
|
|
February 23, 2019 • 3:52 PM Eastern
Quotes delayed 20 minutes
|
Buy (2.60 out of 4)
18th percentile
|
|
